News & Updates

Clinical Trials At Home — Implementing Telemedicine & Virtual Visits During COVID-19

05/08/2020

Excerpt from the article: “There is no denying that the COVID-19 pandemic has spurred tremendous innovation across our industry. Even more impressive is the pace at which we have been able to implement technology solutions that can facilitate continued progress in our critical activities and trials. Most importantly, the expansion of telemedicine and virtual solutions…

Read More

Watch: How does Gilead’s experimental drug remdesivir work against the coronavirus?

05/07/2020

Excerpt from the article: “Gilead Sciences’ experimental drug remdesivir has been gaining traction as a potential Covid-19 treatment, and late last week scored an emergency use authorization from federal regulators for it to be used in patients with the condition.” Click the button below to read the article and watch the video: Continue Reading The…

Read More

The Coronavirus Vaccine Could Be Developed in Philly

05/07/2020

Excerpt from the article: “There is some good news in the fight against the novel coronavirus. More than 100,000 people in the United States who were infected with the virus have since recovered and in many of those who’ve recovered, doctors have discovered coronavirus antibodies, proteins that can potentially be used to fight the virus.…

Read More

In the global race against COVID-19, this Canadian company says it’s moving toward a treatment at ‘breakneck speed’

05/06/2020

Excerpt from the article: “VANCOUVER—A Canadian biotech company says it’s well on its way to developing a treatment for COVID-19 that could help save the lives of those most vulnerable to the virus. And Carl Hansen’s AbCellera Biologics Inc. now has a $175-million vote of confidence from the federal government.” Click the button below to…

Read More

Vaxart Plans to Push COVID-19 Vaccine Candidate into the Clinic

05/04/2020

Excerpt from the article: “Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic.” Click the button below to read the article:…

Read More

Gilead’s remdesivir prevents Covid-19 progression in preclinical study

05/03/2020

Excerpt from the article: A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19. “The animals were infected with the novel coronavirus, SARS-CoV-2. Data announced by the National Institutes of Health (NIH) revealed a significant decrease in clinical disease and reduced lung…

Read More

Nuritas Leverages AI Platform to Identify Therapeutic Peptides for the Treatment of COVID-19

05/02/2020

Excerpt from the article: “CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nuritas, a biotechnology company that is revolutionizing the discovery and use of therapeutic peptides through artificial intelligence (AI) and genomics, today announced that it has received a grant from Partnership for Advanced Computing in Europe (PRACE) to identify therapeutic peptides for the treatment of patients with COVID-19. Under the…

Read More

How Johnson & Johnson is Mobilizing Their Resources to Help Find Solutions for Covid-1

05/01/2020

J&J is launching a new video series documenting their process towards developing a vaccine for COVID-19. Excerpt from their announcement: “This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine. Each week our host Lisa Ling will talk…

Read More

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference

04/30/2020

Excerpt from the press release: “PLYMOUTH MEETING, Pa. and SEOUL, South Korea, April 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO) and GeneOne Life Science (KSE:011000) today announced interim data through week 16 from a Phase 1/2a trial of DNA vaccine INO-4700 (also called GLS-5300) for MERS coronavirus (MERS-CoV). Vaccine recipients demonstrated strong antibody and T cell immune…

Read More

How BlueDot spots warning signs of pandemics

04/29/2020

Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives